Stay updated with breaking news from Anders Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Sanofi - Aventis Groupe, Press Release: FDA grants efanesoctocog alfa Breakthrough Therapy designation for hemophilia A
Efanesoctocog alfa is the first factor VIII therapy to be awarded Breakthrough Therapy designation by the FDA Designation is based on XTEND-1 phase 3 study data demonstrating a clinically
Designation is based on XTEND-1 phase 3 study data demonstrating a clinically meaningful prevention of...
FDA grants efanesoctocog alfa Breakthrough Therapy designation for hemophilia A Efanesoctocog alfa is the first factor VIII therapy to be awarded Breakthrough Therapy designation by the FDADesignation
01.06.2022 - FDA grants efanesoctocog alfa Breakthrough Therapy designation for hemophilia A Efanesoctocog alfa is the first factor VIII therapy to be awarded Breakthrough Therapy designation by the FDADesignation is based on XTEND-1 Phase 3 study data ... Seite 1